These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19056315)

  • 21. Modelling approaches for angiogenesis.
    Taraboletti G; Giavazzi R
    Eur J Cancer; 2004 Apr; 40(6):881-9. PubMed ID: 15120043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological quantitation of tumour angiogenesis.
    Fox SB; Harris AL
    APMIS; 2004; 112(7-8):413-30. PubMed ID: 15563306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
    Yang AD; Bauer TW; Camp ER; Somcio R; Liu W; Fan F; Ellis LM
    Cancer; 2005 Apr; 103(8):1561-70. PubMed ID: 15754332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angiogenesis in the chronic inflammatory diseases and malignancies].
    Mizia-Malarz A; Sobol G; Woś H
    Pol Merkur Lekarski; 2008 Mar; 24(141):185-9. PubMed ID: 18634281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery.
    Bouzin C; Feron O
    Drug Resist Updat; 2007 Jun; 10(3):109-20. PubMed ID: 17452119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges.
    Siveen KS; Prabhu K; Krishnankutty R; Kuttikrishnan S; Tsakou M; Alali FQ; Dermime S; Mohammad RM; Uddin S
    Curr Vasc Pharmacol; 2017; 15(4):339-351. PubMed ID: 28056756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis.
    Crivellato E; Nico B; Ribatti D
    Cancer Lett; 2008 Sep; 269(1):1-6. PubMed ID: 18450371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor and its relationship to inflammatory mediators.
    Angelo LS; Kurzrock R
    Clin Cancer Res; 2007 May; 13(10):2825-30. PubMed ID: 17504979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF-targeted therapy: mechanisms of anti-tumour activity.
    Ellis LM; Hicklin DJ
    Nat Rev Cancer; 2008 Aug; 8(8):579-91. PubMed ID: 18596824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
    Lohela M; Bry M; Tammela T; Alitalo K
    Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases.
    Chantrain CF; Henriet P; Jodele S; Emonard H; Feron O; Courtoy PJ; DeClerck YA; Marbaix E
    Eur J Cancer; 2006 Feb; 42(3):310-8. PubMed ID: 16406506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostatic complications of angiogenesis inhibitors in cancer patients.
    Elice F; Jacoub J; Rickles FR; Falanga A; Rodeghiero F
    Am J Hematol; 2008 Nov; 83(11):862-70. PubMed ID: 18819092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour vascularization: sprouting angiogenesis and beyond.
    Hillen F; Griffioen AW
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):489-502. PubMed ID: 17717633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor angiogenesis].
    Lukesová S; Kopecký O; Dvorák J; Hlávková D; Vroblová V
    Vnitr Lek; 2006 Sep; 52(9):797-800. PubMed ID: 17091603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular damaging agents.
    Patterson DM; Rustin GJ
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):443-56. PubMed ID: 17459681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiogenesis and radiotherapy (vessels, anaemia, oxygen and radiosensitivity)].
    Lartigau E
    Bull Cancer; 2007 Jul; 94 Spec No():S197-202. PubMed ID: 17846005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coupled modelling of tumour angiogenesis, tumour growth and blood perfusion.
    Cai Y; Xu S; Wu J; Long Q
    J Theor Biol; 2011 Jun; 279(1):90-101. PubMed ID: 21392511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulating the tumor microenvironment to improve radiotherapy.
    Maity A
    Retina; 2009 Jun; 29(6 Suppl):S32-3. PubMed ID: 19553796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiopoietins in malignancy.
    Bach F; Uddin FJ; Burke D
    Eur J Surg Oncol; 2007 Feb; 33(1):7-15. PubMed ID: 16962282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.